Talphera, Inc. (NASDAQ:TLPH) Sees Significant Increase in Short Interest

Talphera, Inc. (NASDAQ:TLPH) saw a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 59,800 shares, a growth of 42.7% from the November 30th total of 41,900 shares. Approximately 0.4% of the shares of the company are sold short. Based on an average daily volume of 99,000 shares, the days-to-cover ratio is currently 0.6 days.

Talphera Stock Up 5.0 %

NASDAQ TLPH traded up $0.03 during trading hours on Friday, hitting $0.53. 163,105 shares of the stock were exchanged, compared to its average volume of 92,952. The company has a market cap of $9.03 million, a price-to-earnings ratio of -0.77 and a beta of 0.25. Talphera has a 12-month low of $0.50 and a 12-month high of $1.61. The stock has a 50-day moving average of $0.77 and a 200 day moving average of $0.86.

Hedge Funds Weigh In On Talphera

Large investors have recently modified their holdings of the business. Turtle Creek Wealth Advisors LLC purchased a new stake in Talphera during the second quarter worth about $64,000. Rosalind Advisors Inc. purchased a new position in Talphera in the 3rd quarter valued at approximately $650,000. Finally, Nantahala Capital Management LLC purchased a new stake in Talphera during the second quarter worth $1,773,000. 37.67% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Maxim Group raised Talphera to a “strong-buy” rating in a report on Friday, November 8th.

About Talphera

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.